4549 logo

Eiken Chemical Co., Ltd. Stock Price

TSE:4549 Community·JP¥77.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4549 Share Price Performance

JP¥2,354.00
72.00 (3.16%)
JP¥2,354.00
72.00 (3.16%)
Price JP¥2,354.00

4549 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

2 Risks
2 Rewards

Eiken Chemical Co., Ltd. Key Details

JP¥41.2b

Revenue

JP¥24.6b

Cost of Revenue

JP¥16.7b

Gross Profit

JP¥12.8b

Other Expenses

JP¥3.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Jan 30, 2026
119.03
40.44%
9.45%
6.8%
View Full Analysis

About 4549

Founded
1939
Employees
702
CEO
Yuji Segawa
WebsiteView website
www.eiken.co.jp

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.

Recent 4549 News & Updates

Recent updates

No updates